Tas::75 0872::Tas Translational Nanomedicaltherapies For Cardiac &Vascular Dis View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2010-2015

FUNDING AMOUNT

16447515 USD

ABSTRACT

The overall goal of this PEN application is the development and imaging-facilitated evaluation of translational nanotechnology-based tools, and the development of associated multidisciplinary trainees, focused on the treatment of heart failure and atherosclerosis. We will apply nanotechnology to address the aforementioned cardiovascular diseases and integrate expertise in multiple disciplines, including vascular biology, tissue engineering, drug delivery, molecular biology, diagnostic imaging, chemistry, physics, bioengineering, and clinical sciences. Our multidisciplinary team includes investigators from Mount Sinai School of Medicine (MSSM), Massachusetts Institute of Technology (MIT), New York University (NYU), Columbia University (Columbia), and Brigham and Women's Hospital (BWH). Under the leadership of Zahi Fayad (MSSM) and Robert Langer (MIT), the application is structured to facilitate a synergistic interaction among the different investigators, to maximize clinical translation of the nanotechnology to biomedical and clinical problems, to optimize the design of nanotechnology components, and to train the next generation of engineers, scientists, and clinicians with the multidisciplinary skills to exploit nanotechnology towards eliminating the burdens of cardiovascular disease. The program consists of 3 innovative and translational research projects that utilize nanotechnology to tackle specific cardiac and vascular problems and thereby treat cardiovascular disease. Project 1 (Hajjar, Langer, Costa) will investigate minimally invasive nanotechnology-based approaches to deliver regeneration factors to the infarcted myocardium. In Project 2 (Fisher, Tabas, Langer, Farokhzad) novel nanotherapeutic approaches for defective inflammation resolution in atherosclerosis will be developed. Project 3 (Fayad, Mulder, Fuster, Langer) will develop a theranostic nanoparticle platform with surface activation properties to efficiently and specifically target and image macrophages in atherosclerotic plaques. All projects have a high degree of translational potential as well as a strong emphasis on developing state-of-the-art nanotechnology, with the balance between translation and technology varying among the 3 projects to create attractive and diverse platforms that are aligned with the overall goal of the NHLBI Programs of Excellence in Nanotechnology. Moreover, we chose to focus the different projects at two stages of cardiovascular disease, namely the (early) atherosclerotic inflammatory process and (late) myocardial regeneration after infarction. All 3 projects offer outstanding opportunities for the training and professional development of graduate students and postdoctoral fellows with the multidisciplinary skills required to apply nanotechnology in the context of cardiovascular disease. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8175621

Related SciGraph Publications

  • 2018-07-10. Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits in EXPERIMENTAL MODELS OF CARDIOVASCULAR DISEASES
  • 2017-12. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics in NATURE COMMUNICATIONS
  • 2017-03-20. Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis in NATURE COMMUNICATIONS
  • 2017. Lipidoid mRNA Nanoparticles for Myocardial Delivery in Rodents in CARDIAC GENE THERAPY
  • 2017. Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells in CARDIAC GENE THERAPY
  • 2016. The Use of Silk in Nanomedicine Applications in NANOMEDICINE
  • 2015-12. Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy in NATURE COMMUNICATIONS
  • 2015-12. Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure in NATURE COMMUNICATIONS
  • 2015-12. Nanoparticles with photoinduced precipitation for the extraction of pollutants from water and soil in NATURE COMMUNICATIONS
  • 2014-12. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation in NATURE COMMUNICATIONS
  • 2014-08. Non-viral vectors for gene-based therapy in NATURE REVIEWS GENETICS
  • 2014-04. Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure in GENE THERAPY
  • 2014-04. Inhibition of miR-25 improves cardiac contractility in the failing heart in NATURE
  • 2013-12. SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries in JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
  • 2013-07. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling in NATURE BIOTECHNOLOGY
  • 2013-03. Letter to the Editor re: Spectral Hounsfield units—a new radiological concept in EUROPEAN RADIOLOGY
  • 2013-02. Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis in CURRENT CARDIOVASCULAR IMAGING REPORTS
  • 2013-02. Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases in CURRENT CARDIOVASCULAR IMAGING REPORTS
  • 2012-12. Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy in NATURE REVIEWS CARDIOLOGY
  • 2012-10. Microfluidic technologies for accelerating the clinical translation of nanoparticles in NATURE NANOTECHNOLOGY
  • 2012-10. Molecular Imaging in Atherosclerosis: FDG PET in CURRENT ATHEROSCLEROSIS REPORTS
  • 2012-02. Nanomedical Theranostics in Cardiovascular Disease in CURRENT CARDIOVASCULAR IMAGING REPORTS
  • 2011-11. Perspectives and opportunities for nanomedicine in the management of atherosclerosis in NATURE REVIEWS DRUG DISCOVERY
  • 2011-10. Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model in GENE THERAPY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2209", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "16447515"
        }, 
        "description": "The overall goal of this PEN application is the development and imaging-facilitated evaluation of translational nanotechnology-based tools, and the development of associated multidisciplinary trainees, focused on the treatment of heart failure and atherosclerosis. We will apply nanotechnology to address the aforementioned cardiovascular diseases and integrate expertise in multiple disciplines, including vascular biology, tissue engineering, drug delivery, molecular biology, diagnostic imaging, chemistry, physics, bioengineering, and clinical sciences. Our multidisciplinary team includes investigators from Mount Sinai School of Medicine (MSSM), Massachusetts Institute of Technology (MIT), New York University (NYU), Columbia University (Columbia), and Brigham and Women's Hospital (BWH). Under the leadership of Zahi Fayad (MSSM) and Robert Langer (MIT), the application is structured to facilitate a synergistic interaction among the different investigators, to maximize clinical translation of the nanotechnology to biomedical and clinical problems, to optimize the design of nanotechnology components, and to train the next generation of engineers, scientists, and clinicians with the multidisciplinary skills to exploit nanotechnology towards eliminating the burdens of cardiovascular disease. The program consists of 3 innovative and translational research projects that utilize nanotechnology to tackle specific cardiac and vascular problems and thereby treat cardiovascular disease. Project 1 (Hajjar, Langer, Costa) will investigate minimally invasive nanotechnology-based approaches to deliver regeneration factors to the infarcted myocardium. In Project 2 (Fisher, Tabas, Langer, Farokhzad) novel nanotherapeutic approaches for defective inflammation resolution in atherosclerosis will be developed. Project 3 (Fayad, Mulder, Fuster, Langer) will develop a theranostic nanoparticle platform with surface activation properties to efficiently and specifically target and image macrophages in atherosclerotic plaques. All projects have a high degree of translational potential as well as a strong emphasis on developing state-of-the-art nanotechnology, with the balance between translation and technology varying among the 3 projects to create attractive and diverse platforms that are aligned with the overall goal of the NHLBI Programs of Excellence in Nanotechnology. Moreover, we chose to focus the different projects at two stages of cardiovascular disease, namely the (early) atherosclerotic inflammatory process and (late) myocardial regeneration after infarction. All 3 projects offer outstanding opportunities for the training and professional development of graduate students and postdoctoral fellows with the multidisciplinary skills required to apply nanotechnology in the context of cardiovascular disease.", 
        "endDate": "2015-08-12T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.279885.9", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2345462", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2345462"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "268201000045C-0-0-1"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "myocardium", 
          "multiple disciplines", 
          "approach", 
          "physics", 
          "invasive nanotechnology", 
          "scientists", 
          "outstanding opportunity", 
          "Mount Sinai School", 
          "molecular biology", 
          "expertise", 
          "translational research projects", 
          "development", 
          "different projects", 
          "professional development", 
          "atherosclerotic plaques", 
          "clinical problems", 
          "high degree", 
          "vascular problems", 
          "diverse platforms", 
          "surface activation properties", 
          "program", 
          "BWH", 
          "Fayad", 
          "Mulder", 
          "macrophages", 
          "overall goal", 
          "strong emphasis", 
          "design", 
          "translation", 
          "application", 
          "nanotherapeutic approaches", 
          "leadership", 
          "chemistry", 
          "Robert Langer", 
          "novel", 
          "multidisciplinary team", 
          "graduate students", 
          "clinical science", 
          "multidisciplinary trainees", 
          "art nanotechnology", 
          "Farokhzad", 
          "postdoctoral fellows", 
          "nanotechnology components", 
          "Costa", 
          "Brigham", 
          "Women's Hospital", 
          "atherosclerosis", 
          "diagnostic imaging", 
          "nanotechnology", 
          "Fisher", 
          "theranostic nanoparticle platform", 
          "stage", 
          "Langer", 
          "infarction", 
          "Project 3", 
          "defective inflammation resolution", 
          "evaluation", 
          "excellence", 
          "next generation", 
          "regeneration factor", 
          "investigators", 
          "balance", 
          "Columbia", 
          "Project 1", 
          "CARDIAC &VASCULAR DIS", 
          "translational nanotechnology", 
          "NHLBI Programs", 
          "translational potential", 
          "MIT", 
          "training", 
          "Massachusetts Institute", 
          "MSSM", 
          "TAS::75 0872::TAS", 
          "vascular biology", 
          "multidisciplinary skills", 
          "tool", 
          "cardiovascular disease", 
          "atherosclerotic inflammatory process", 
          "context", 
          "Project 2", 
          "technology", 
          "PEN application", 
          "tissue engineering", 
          "Fuster", 
          "drug delivery", 
          "Zahi Fayad", 
          "TRANSLATIONAL NANOMEDICALTHERAPIES", 
          "engineers", 
          "clinical translation", 
          "project", 
          "heart failure", 
          "myocardial regeneration", 
          "different investigators", 
          "burden", 
          "synergistic interaction", 
          "aforementioned cardiovascular diseases", 
          "medicine", 
          "clinicians", 
          "Tabas", 
          "Hajjar", 
          "bioengineering", 
          "New York University", 
          "treatment", 
          "Columbia University", 
          "state", 
          "imaging"
        ], 
        "name": "TAS::75 0872::TAS  TRANSLATIONAL NANOMEDICALTHERAPIES FOR CARDIAC &VASCULAR DIS", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.59734.3c", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.59734.3c", 
              "name": "ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI", 
              "type": "Organization"
            }, 
            "familyName": "FAYAD", 
            "givenName": "ZAHI", 
            "id": "sg:person.0772637666.38", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.0772637666.38", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2345462"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T11:56", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects.xml.gz", 
        "startDate": "2010-08-13T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8175621"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2345462'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2345462'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2345462'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2345462'


     

    This table displays all metadata directly associated to this object as RDF triples.

    153 TRIPLES      19 PREDICATES      129 URIs      120 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2345462 schema:about anzsrc-for:2209
    2 anzsrc-for:2211
    3 schema:amount N1b1aabe3952d433c8c7236158821b0c0
    4 schema:description The overall goal of this PEN application is the development and imaging-facilitated evaluation of translational nanotechnology-based tools, and the development of associated multidisciplinary trainees, focused on the treatment of heart failure and atherosclerosis. We will apply nanotechnology to address the aforementioned cardiovascular diseases and integrate expertise in multiple disciplines, including vascular biology, tissue engineering, drug delivery, molecular biology, diagnostic imaging, chemistry, physics, bioengineering, and clinical sciences. Our multidisciplinary team includes investigators from Mount Sinai School of Medicine (MSSM), Massachusetts Institute of Technology (MIT), New York University (NYU), Columbia University (Columbia), and Brigham and Women's Hospital (BWH). Under the leadership of Zahi Fayad (MSSM) and Robert Langer (MIT), the application is structured to facilitate a synergistic interaction among the different investigators, to maximize clinical translation of the nanotechnology to biomedical and clinical problems, to optimize the design of nanotechnology components, and to train the next generation of engineers, scientists, and clinicians with the multidisciplinary skills to exploit nanotechnology towards eliminating the burdens of cardiovascular disease. The program consists of 3 innovative and translational research projects that utilize nanotechnology to tackle specific cardiac and vascular problems and thereby treat cardiovascular disease. Project 1 (Hajjar, Langer, Costa) will investigate minimally invasive nanotechnology-based approaches to deliver regeneration factors to the infarcted myocardium. In Project 2 (Fisher, Tabas, Langer, Farokhzad) novel nanotherapeutic approaches for defective inflammation resolution in atherosclerosis will be developed. Project 3 (Fayad, Mulder, Fuster, Langer) will develop a theranostic nanoparticle platform with surface activation properties to efficiently and specifically target and image macrophages in atherosclerotic plaques. All projects have a high degree of translational potential as well as a strong emphasis on developing state-of-the-art nanotechnology, with the balance between translation and technology varying among the 3 projects to create attractive and diverse platforms that are aligned with the overall goal of the NHLBI Programs of Excellence in Nanotechnology. Moreover, we chose to focus the different projects at two stages of cardiovascular disease, namely the (early) atherosclerotic inflammatory process and (late) myocardial regeneration after infarction. All 3 projects offer outstanding opportunities for the training and professional development of graduate students and postdoctoral fellows with the multidisciplinary skills required to apply nanotechnology in the context of cardiovascular disease.
    5 schema:endDate 2015-08-12T00:00:00Z
    6 schema:funder https://www.grid.ac/institutes/grid.279885.9
    7 schema:identifier N1c8227b24e464c3486ded86a4813ca52
    8 N71087f1ac9e7487a903788921c574b8e
    9 schema:inLanguage en
    10 schema:keywords BWH
    11 Brigham
    12 CARDIAC &VASCULAR DIS
    13 Columbia
    14 Columbia University
    15 Costa
    16 Farokhzad
    17 Fayad
    18 Fisher
    19 Fuster
    20 Hajjar
    21 Langer
    22 MIT
    23 MSSM
    24 Massachusetts Institute
    25 Mount Sinai School
    26 Mulder
    27 NHLBI Programs
    28 New York University
    29 PEN application
    30 Project 1
    31 Project 2
    32 Project 3
    33 Robert Langer
    34 TAS::75 0872::TAS
    35 TRANSLATIONAL NANOMEDICALTHERAPIES
    36 Tabas
    37 Women's Hospital
    38 Zahi Fayad
    39 aforementioned cardiovascular diseases
    40 application
    41 approach
    42 art nanotechnology
    43 atherosclerosis
    44 atherosclerotic inflammatory process
    45 atherosclerotic plaques
    46 balance
    47 bioengineering
    48 burden
    49 cardiovascular disease
    50 chemistry
    51 clinical problems
    52 clinical science
    53 clinical translation
    54 clinicians
    55 context
    56 defective inflammation resolution
    57 design
    58 development
    59 diagnostic imaging
    60 different investigators
    61 different projects
    62 diverse platforms
    63 drug delivery
    64 engineers
    65 evaluation
    66 excellence
    67 expertise
    68 graduate students
    69 heart failure
    70 high degree
    71 imaging
    72 infarction
    73 invasive nanotechnology
    74 investigators
    75 leadership
    76 macrophages
    77 medicine
    78 molecular biology
    79 multidisciplinary skills
    80 multidisciplinary team
    81 multidisciplinary trainees
    82 multiple disciplines
    83 myocardial regeneration
    84 myocardium
    85 nanotechnology
    86 nanotechnology components
    87 nanotherapeutic approaches
    88 next generation
    89 novel
    90 outstanding opportunity
    91 overall goal
    92 physics
    93 postdoctoral fellows
    94 professional development
    95 program
    96 project
    97 regeneration factor
    98 scientists
    99 stage
    100 state
    101 strong emphasis
    102 surface activation properties
    103 synergistic interaction
    104 technology
    105 theranostic nanoparticle platform
    106 tissue engineering
    107 tool
    108 training
    109 translation
    110 translational nanotechnology
    111 translational potential
    112 translational research projects
    113 treatment
    114 vascular biology
    115 vascular problems
    116 schema:name TAS::75 0872::TAS TRANSLATIONAL NANOMEDICALTHERAPIES FOR CARDIAC &VASCULAR DIS
    117 schema:recipient N28eca57d6ffc43d58a23ce8b2ce5b575
    118 sg:person.0772637666.38
    119 https://www.grid.ac/institutes/grid.59734.3c
    120 schema:sameAs https://app.dimensions.ai/details/grant/grant.2345462
    121 schema:sdDatePublished 2019-03-07T11:56
    122 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    123 schema:sdPublisher Nf3784f076f264cd6b0f90d9ffa0b6931
    124 schema:startDate 2010-08-13T00:00:00Z
    125 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8175621
    126 sgo:license sg:explorer/license/
    127 sgo:sdDataset grants
    128 rdf:type schema:MonetaryGrant
    129 N1b1aabe3952d433c8c7236158821b0c0 schema:currency USD
    130 schema:value 16447515
    131 rdf:type schema:MonetaryAmount
    132 N1c8227b24e464c3486ded86a4813ca52 schema:name nih_id
    133 schema:value 268201000045C-0-0-1
    134 rdf:type schema:PropertyValue
    135 N28eca57d6ffc43d58a23ce8b2ce5b575 schema:member sg:person.0772637666.38
    136 schema:roleName PI
    137 rdf:type schema:Role
    138 N71087f1ac9e7487a903788921c574b8e schema:name dimensions_id
    139 schema:value 2345462
    140 rdf:type schema:PropertyValue
    141 Nf3784f076f264cd6b0f90d9ffa0b6931 schema:name Springer Nature - SN SciGraph project
    142 rdf:type schema:Organization
    143 anzsrc-for:2209 schema:inDefinedTermSet anzsrc-for:
    144 rdf:type schema:DefinedTerm
    145 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    146 rdf:type schema:DefinedTerm
    147 sg:person.0772637666.38 schema:affiliation https://www.grid.ac/institutes/grid.59734.3c
    148 schema:familyName FAYAD
    149 schema:givenName ZAHI
    150 rdf:type schema:Person
    151 https://www.grid.ac/institutes/grid.279885.9 schema:Organization
    152 https://www.grid.ac/institutes/grid.59734.3c schema:name ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    153 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...